1. Home
  2. KYMR vs TR Comparison

KYMR vs TR Comparison

Compare KYMR & TR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • TR
  • Stock Information
  • Founded
  • KYMR 2015
  • TR 1896
  • Country
  • KYMR United States
  • TR United States
  • Employees
  • KYMR N/A
  • TR N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • TR Specialty Foods
  • Sector
  • KYMR Health Care
  • TR Consumer Staples
  • Exchange
  • KYMR Nasdaq
  • TR Nasdaq
  • Market Cap
  • KYMR 3.1B
  • TR 2.5B
  • IPO Year
  • KYMR 2020
  • TR N/A
  • Fundamental
  • Price
  • KYMR $44.64
  • TR $34.97
  • Analyst Decision
  • KYMR Strong Buy
  • TR
  • Analyst Count
  • KYMR 16
  • TR 0
  • Target Price
  • KYMR $58.94
  • TR N/A
  • AVG Volume (30 Days)
  • KYMR 865.2K
  • TR 334.9K
  • Earning Date
  • KYMR 08-06-2025
  • TR 08-07-2025
  • Dividend Yield
  • KYMR N/A
  • TR 1.03%
  • EPS Growth
  • KYMR N/A
  • TR N/A
  • EPS
  • KYMR N/A
  • TR 1.21
  • Revenue
  • KYMR $58,885,000.00
  • TR $718,497,000.00
  • Revenue This Year
  • KYMR $58.26
  • TR N/A
  • Revenue Next Year
  • KYMR N/A
  • TR N/A
  • P/E Ratio
  • KYMR N/A
  • TR $28.63
  • Revenue Growth
  • KYMR N/A
  • TR N/A
  • 52 Week Low
  • KYMR $19.45
  • TR $26.78
  • 52 Week High
  • KYMR $53.27
  • TR $36.25
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 55.84
  • TR 55.53
  • Support Level
  • KYMR $43.56
  • TR $33.67
  • Resistance Level
  • KYMR $46.34
  • TR $35.71
  • Average True Range (ATR)
  • KYMR 1.81
  • TR 0.91
  • MACD
  • KYMR -0.60
  • TR 0.04
  • Stochastic Oscillator
  • KYMR 36.21
  • TR 72.30

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About TR Tootsie Roll Industries Inc.

Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.

Share on Social Networks: